GW Pharma beats analyst projections with $108M in Q4 sales thanks to CBD drug

GW Pharma beats analyst projections with 8M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […] GW Pharma beats analyst projections with $108M in Q4 sales thanks to CBD drug is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Excerpt only …
READ MORE BELOW
Source : MJ DAILY EUROPE
Link to original : GW Pharma beats analyst projections with 8M in Q4 sales thanks to CBD drug
reposted by Cannabis News World

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.